Glaxosmithkline Holdings (Ireland) Limited

Company Name	Glaxosmithkline Holdings (Ireland) Limited
Company Status	Dissolved
Company Number	09163001
Category	Private Limited Company
Incorporation Date	5 August 2014(9 years, 8 months ago)
Dissolution Date	28 September 2021 (2 years, 7 months ago)

Business Activity

Section M	Professional, scientific and technical activities
SIC 70221	Financial management

Directors

Director Name	Mrs Ciara Martha Lynch
Date of Birth	July 1968 (Born 55 years ago)
Nationality	Irish
Status	Closed
Appointed	02 March 2020(5 years, 7 months after company formation)
Appointment Duration	1 year, 6 months (closed 28 September 2021)
Role	Accountant
Country of Residence	England
Correspondence Address	980 Great West Road Brentford TW8 9GS

Secretary Name	Edinburgh Pharmaceutical Industries Limited (Corporation)
Status	Closed
Appointed	05 August 2014(same day as company formation)
Correspondence Address	Shewalton Road Irvine Ayreshire KA11 5AP Scotland

Director Name	Glaxo Group Limited (Corporation)
Status	Closed
Appointed	29 August 2014(3 weeks, 3 days after company formation)
Appointment Duration	7 years, 1 month (closed 28 September 2021)
Correspondence Address	980 Great West Road Brentford Middlesex TW8 9GS

Director Name	Edinburgh Pharmaceutical Industries Limited (Corporation)
Status	Closed
Appointed	29 August 2014(3 weeks, 3 days after company formation)
Appointment Duration	7 years, 1 month (closed 28 September 2021)
Correspondence Address	Shewalton Road Shewalton Road Irvine Ayrshire KA11 5AP Scotland

Director Name	Desmond Burke
Date of Birth	December 1959 (Born 64 years ago)
Nationality	Irish
Status	Resigned
Appointed	05 August 2014(same day as company formation)
Role	Commercial Director
Country of Residence	Republic Of Ireland
Correspondence Address	Glaxosmithkline Currabiny, Carrigaline County Cork -

Director Name	Michael Cuddihy
Date of Birth	December 1957 (Born 66 years ago)
Nationality	Irish
Status	Resigned
Appointed	05 August 2014(same day as company formation)
Role	Logistics Director
Country of Residence	Republic Of Ireland
Correspondence Address	Glaxosmithkline Currabinny, Carrigaline County Cork -

Director Name	Joe Power
Date of Birth	February 1964 (Born 60 years ago)
Nationality	Irish
Status	Resigned
Appointed	05 August 2014(same day as company formation)
Role	Site Director
Country of Residence	Republic Of Ireland
Correspondence Address	Glaxosmithkline Currabinny, Carrigaline County Cork -

Director Name	Mr Paul Blackburn
Date of Birth	October 1994 (Born 29 years ago)
Nationality	British
Status	Resigned
Appointed	29 August 2014(3 weeks, 3 days after company formation)
Appointment Duration	1 year, 6 months (resigned 01 March 2016)
Role	Company Director
Country of Residence	England
Correspondence Address	980 Great West Road Brentford Middlesex TW8 9GS

Director Name	Mr Alan George Burns
Date of Birth	March 1975 (Born 49 years ago)
Nationality	British
Status	Resigned
Appointed	29 August 2014(3 weeks, 3 days after company formation)
Appointment Duration	4 years, 8 months (resigned 08 May 2019)
Role	Company Director
Country of Residence	England
Correspondence Address	980 Great West Road Brentford Middlesex TW8 9GS

Director Name	Mr Adam Walker
Date of Birth	November 1967 (Born 56 years ago)
Nationality	British
Status	Resigned
Appointed	03 June 2015(10 months after company formation)
Appointment Duration	4 years, 9 months (resigned 02 March 2020)
Role	Company Director
Country of Residence	United Kingdom
Correspondence Address	980 Great West Road Brentford Middlesex TW8 9GS

Director Name	Mr Oleg Dubianskij
Date of Birth	February 1972 (Born 52 years ago)
Nationality	Lithuanian
Status	Resigned
Appointed	31 January 2017(2 years, 6 months after company formation)
Appointment Duration	2 years (resigned 13 February 2019)
Role	Financial Controller
Country of Residence	United Kingdom
Correspondence Address	980 Great West Road Brentford TW8 9GS

Director Name	Mr James Borger
Date of Birth	January 1963 (Born 61 years ago)
Nationality	American
Status	Resigned
Appointed	25 February 2019(4 years, 6 months after company formation)
Appointment Duration	1 year (resigned 02 March 2020)
Role	Vp, Group Financial Planning And Analysis
Country of Residence	England
Correspondence Address	980 Great West Road Brentford Middlesex TW8 9GS

Contact

Website	gsk.com
Telephone	01280 000000
Telephone region	Buckingham

Location

Registered Address	980 Great West Road Brentford Middlesex TW8 9GS
Region	London
Constituency	Brentford and Isleworth
County	Greater London
Ward	Brentford
Built Up Area	Greater London
Address Matches	Over 50 other UK companies use this postal address

Shareholders

10m at £1	Setfirst LTD 100.00% Ordinary
1 at £1	Setfirst LTD 0.00% Deferred

Financials

Year	2014
Net Worth	£1,828,213,000
Current Liabilities	£10,172,000

Accounts

Latest Accounts	31 December 2019 (4 years, 3 months ago)
Accounts Category	Full
Accounts Year End	31 December

Filing History

13 October 2020	Full accounts made up to 31 December 2019 (23 pages)
11 August 2020	Confirmation statement made on 5 August 2020 with no updates (3 pages)
18 March 2020	Appointment of Mrs Ciara Martha Lynch as a director on 2 March 2020 (2 pages)
18 March 2020	Termination of appointment of James Borger as a director on 2 March 2020 (1 page)
17 March 2020	Termination of appointment of Adam Walker as a director on 2 March 2020 (1 page)
24 September 2019	Full accounts made up to 31 December 2018 (23 pages)
5 August 2019	Confirmation statement made on 5 August 2019 with no updates (3 pages)
6 June 2019	Termination of appointment of Alan George Burns as a director on 8 May 2019 (1 page)
19 March 2019	Appointment of Mr James Borger as a director on 25 February 2019 (2 pages)
18 February 2019	Termination of appointment of Oleg Dubianskij as a director on 13 February 2019 (1 page)
27 September 2018	Full accounts made up to 31 December 2017 (19 pages)
22 August 2018	Confirmation statement made on 5 August 2018 with no updates (3 pages)
11 August 2017	Confirmation statement made on 5 August 2017 with no updates (3 pages)
11 August 2017	Confirmation statement made on 5 August 2017 with no updates (3 pages)
17 July 2017	Full accounts made up to 31 December 2016 (20 pages)
17 July 2017	Full accounts made up to 31 December 2016 (20 pages)
6 February 2017	Appointment of Mr Oleg Dubianskij as a director on 31 January 2017 (2 pages)
6 February 2017	Appointment of Mr Oleg Dubianskij as a director on 31 January 2017 (2 pages)
17 September 2016	Full accounts made up to 31 December 2015 (24 pages)
17 September 2016	Full accounts made up to 31 December 2015 (24 pages)
16 August 2016	Confirmation statement made on 5 August 2016 with updates (5 pages)
16 August 2016	Confirmation statement made on 5 August 2016 with updates (5 pages)
1 March 2016	Termination of appointment of Paul Blackburn as a director on 1 March 2016 (1 page)
1 March 2016	Termination of appointment of Paul Blackburn as a director on 1 March 2016 (1 page)
25 September 2015	Full accounts made up to 31 December 2014 (18 pages)
25 September 2015	Full accounts made up to 31 December 2014 (18 pages)
28 August 2015	Annual return made up to 5 August 2015 with a full list of shareholders Statement of capital on 2015-08-28 GBP 10,000,001 (6 pages)
28 August 2015	Annual return made up to 5 August 2015 with a full list of shareholders Statement of capital on 2015-08-28 GBP 10,000,001 (6 pages)
28 August 2015	Annual return made up to 5 August 2015 with a full list of shareholders Statement of capital on 2015-08-28 GBP 10,000,001 (6 pages)
5 June 2015	Full accounts made up to 28 August 2014 (18 pages)
5 June 2015	Appointment of Mr Adam Walker as a director on 3 June 2015 (2 pages)
5 June 2015	Appointment of Mr Adam Walker as a director on 3 June 2015 (2 pages)
5 June 2015	Full accounts made up to 28 August 2014 (18 pages)
5 June 2015	Appointment of Mr Adam Walker as a director on 3 June 2015 (2 pages)
12 November 2014	Current accounting period shortened from 28 August 2015 to 31 December 2014 (3 pages)
12 November 2014	Current accounting period shortened from 28 August 2015 to 31 December 2014 (3 pages)
3 November 2014	Previous accounting period shortened from 31 August 2015 to 28 August 2014 (3 pages)
3 November 2014	Previous accounting period shortened from 31 August 2015 to 28 August 2014 (3 pages)
28 October 2014	Particulars of variation of rights attached to shares (3 pages)
28 October 2014	Particulars of variation of rights attached to shares (3 pages)
28 October 2014	Change of share class name or designation (2 pages)
28 October 2014	Change of share class name or designation (2 pages)
24 September 2014	Solvency Statement dated 19/09/14 (2 pages)
24 September 2014	Resolutions RES13 ‐ Share premium account cancelled 19/09/2014 (3 pages)
24 September 2014	Statement by Directors (2 pages)
24 September 2014	Solvency Statement dated 19/09/14 (2 pages)
24 September 2014	Statement of capital on 24 September 2014 GBP 10,000,001.00 (5 pages)
24 September 2014	Statement by Directors (2 pages)
24 September 2014	Statement of capital on 24 September 2014 GBP 10,000,001.00 (5 pages)
17 September 2014	Statement of capital following an allotment of shares on 28 August 2014 GBP 10,000,001 (5 pages)
17 September 2014	Particulars of variation of rights attached to shares (3 pages)
17 September 2014	Resolutions RES01 ‐ Resolution of adoption of Articles of Association RES10 ‐ Resolution of allotment of securities RES12 ‐ Resolution of varying share rights or name (23 pages)
17 September 2014	Statement of capital following an allotment of shares on 28 August 2014 GBP 10,000,001 (5 pages)
17 September 2014	Change of share class name or designation (2 pages)
17 September 2014	Resolutions RES12 ‐ Resolution of varying share rights or name RES10 ‐ Resolution of allotment of securities RES01 ‐ Resolution of adoption of Articles of Association RES12 ‐ Resolution of varying share rights or name (23 pages)
17 September 2014	Change of share class name or designation (2 pages)
17 September 2014	Particulars of variation of rights attached to shares (3 pages)
17 September 2014	Resolutions RES01 ‐ Resolution of adoption of Articles of Association (22 pages)
17 September 2014	Resolutions RES01 ‐ Resolution of adoption of Articles of Association RES01 ‐ Resolution of adoption of Articles of Association (22 pages)
2 September 2014	Appointment of Mr Paul Blackburn as a director on 29 August 2014 (2 pages)
2 September 2014	Appointment of Mr Paul Blackburn as a director on 29 August 2014 (2 pages)
2 September 2014	Appointment of Mr Alan Burns as a director on 29 August 2014 (2 pages)
2 September 2014	Appointment of Mr Alan Burns as a director on 29 August 2014 (2 pages)
1 September 2014	Termination of appointment of Michael Cuddihy as a director on 29 August 2014 (1 page)
1 September 2014	Appointment of Edinburgh Pharmaceutical Industries Limited as a director on 29 August 2014 (2 pages)
1 September 2014	Termination of appointment of Desmond Burke as a director on 29 August 2014 (1 page)
1 September 2014	Termination of appointment of Joe Power as a director on 29 August 2014 (1 page)
1 September 2014	Termination of appointment of Desmond Burke as a director on 29 August 2014 (1 page)
1 September 2014	Appointment of Edinburgh Pharmaceutical Industries Limited as a director on 29 August 2014 (2 pages)
1 September 2014	Appointment of Glaxo Group Limited as a director on 29 August 2014 (2 pages)
1 September 2014	Appointment of Glaxo Group Limited as a director on 29 August 2014 (2 pages)
1 September 2014	Termination of appointment of Michael Cuddihy as a director on 29 August 2014 (1 page)
1 September 2014	Termination of appointment of Joe Power as a director on 29 August 2014 (1 page)
5 August 2014	Incorporation (42 pages)
5 August 2014	Incorporation (42 pages)

Glaxosmithkline Holdings (Ireland) Limited

Business Activity

Directors

Contact

Location

Shareholders

Financials

Accounts

Filing History

Contact Companies London